ST. LOUIS OFFICE7700 Forsyth Blvd., Suite 1100St. Louis, MO 63105
As a registered patent attorney, Steve is actively engaged in the preparation and prosecution of U.S. and international patent applications, as well as counseling, licensing and enforcement relating to the biotechnology, chemistry and life sciences areas. His postdoctoral experience and advanced degree in biological sciences combined with his law degree give him the unique ability to analyze complex biotechnology issues as well as navigate regulatory and policy challenges affecting the biotech industry.
Steve provides legal analysis and counseling in technologies related to DNA, RNA, proteins, antibodies, biological therapies, gene therapies, pharmaceuticals, drug conjugates, medical and research diagnostic assays, biomarkers, protein chemistry, molecular cloning, protein expression, cell culture and development, immunohistochemistry, delivery of pharmaceutical and biological molecules, nanotechnology, microfluidics, microencapsulation, transgenic animals, transgenic oils, transgenic plants, biofuels, skin science, absorbent materials, food science, pediatric and adult nutritionals, and agricultural biotechnology. Other subject areas include electrochemical cells, hydrogen generator cells and fuel cells. Steve also counsels clients regarding patent and FDA strategy under the Drug Price Competition and Patent Term Restoration Act (Hatch-Waxman) and the Biologics Price Competition and Innovation Act of 2009. He also prepares freedom-to-operate, infringement, invalidity and patentability opinions, and performs intellectual property due diligence analyses. He also guides clients in post grant proceedings including Inter Partes Review and Post Grant Review.